Literature DB >> 24644539

IgM nephropathy; time to act.

Muhammed Mubarak1.   

Abstract

Implication for health policy/practice/research/medical education: Much has been published on the epidemiology and clinicopathological characteristics of IgM nephropathy, but there is little information on the etiology,pathogenesis and specific therapy of the disease. Controversy still shrouds the definition and nosologic status of the disease. Well-coordinated and concerted international efforts and collaboration between researchers in the developing and developed countries are needed to make further progress on the above aspects of the disease.

Entities:  

Keywords:  IgA nephropathy; IgM nephropathy; Minimal change disease

Year:  2014        PMID: 24644539      PMCID: PMC3956903          DOI: 10.12860/jnp.2014.05

Source DB:  PubMed          Journal:  J Nephropathol        ISSN: 2251-8363


  30 in total

1.  Oxford classification of IgA nephropathy: Broadening the scope of the classification.

Authors:  Muhammed Mubarak
Journal:  J Nephropathol       Date:  2012-04-05

2.  No evidence for a specific role of IgM in mesangial proliferation of idiopathic nephrotic syndrome.

Authors:  Y Ji-Yun; T Melvin; R Sibley; A F Michael
Journal:  Kidney Int       Date:  1984-01       Impact factor: 10.612

3.  Immunopathologic study of minimal change glomerular disease with mesangial IgM deposits.

Authors:  T Cavallo; M P Johnson
Journal:  Nephron       Date:  1981       Impact factor: 2.847

4.  IgM nephropathy in India: a single centre experience.

Authors:  Aruna V Vanikar; Kamal V Kanodia; Rashmi D Patel; Kamlesh S Suthar; Himanshu V Patel; Manoj R Gumber; Hargovind L Trivedi
Journal:  Indian J Pediatr       Date:  2012-08       Impact factor: 1.967

5.  Early recurrence of nephrotic syndrome (immunoglobulin m nephropathy) after renal transplantation successfully treated with combinations of plasma exchanges, immunoglobulin, and rituximab.

Authors:  S Westphal; S Hansson; L Mjörnstedt; J Mölne; S Swerkersson; S Friman
Journal:  Transplant Proc       Date:  2006-10       Impact factor: 1.066

6.  Clinical and immunopathologic study of mesangial IgM nephropathy: report of 41 cases.

Authors:  H C Hsu; W Y Chen; G J Lin; L Chen; S L Kao; C C Huang; C Y Lin
Journal:  Histopathology       Date:  1984-05       Impact factor: 5.087

7.  Mesangial proliferative glomerulonephritis.

Authors:  H K Bhasin; J G Abuelo; R Nayak; A R Esparza
Journal:  Lab Invest       Date:  1978-07       Impact factor: 5.662

8.  The clinical significance of mesangial IgM deposits and mesangial hypercellularity in minimal change nephrotic syndrome.

Authors:  V Pardo; I Riesgo; G Zilleruelo; J Strauss
Journal:  Am J Kidney Dis       Date:  1984-01       Impact factor: 8.860

9.  IgM-associated glomerulonephritis.

Authors:  H Helin; J Mustonen; A Pasternack; J Antonen
Journal:  Nephron       Date:  1982       Impact factor: 2.847

10.  Clinical follow-up of 54 patients with IgM-nephropathy.

Authors:  H Saha; J Mustonen; A Pasternack; H Helin
Journal:  Am J Nephrol       Date:  1989       Impact factor: 3.754

View more
  6 in total

Review 1.  Case Report: Acute Cerebellar Thrombosis in an Adult Patient with IgM Nephropathy.

Authors:  Abimbola Adike; Mariyam Cherry; Melina Awar
Journal:  Methodist Debakey Cardiovasc J       Date:  2015 Oct-Dec

2.  Pathological and Evolutive Correlations in Steroid Resistant Nephrotic Syndrome in Children.

Authors:  Iuliana Magdalena Starcea; Roxana Alexandra Bogos; Georgiana Scurtu; Mihaela Munteanu; Radu Russu; Vasile Valeriu Lupu; Ancuta Lupu; Laura Trandafir; Ingrith Crenguta Miron; Maria Adriana Mocanu
Journal:  Int J Gen Med       Date:  2022-04-19

3.  Association of apoptosis inhibitor of macrophage (AIM) expression with urinary protein and kidney dysfunction.

Authors:  Megumi Oshima; Yasunori Iwata; Kengo Furuichi; Norihiko Sakai; Miho Shimizu; Akinori Hara; Shinji Kitajima; Tadashi Toyama; Yasuyuki Shinozaki; Akihiro Sagara; Eri Umeda; Shuichi Kaneko; Satoko Arai; Toru Miyazaki; Takashi Wada
Journal:  Clin Exp Nephrol       Date:  2016-02-05       Impact factor: 2.801

4.  World Kidney Day 2014; Chronic Kidney Disease and Aging: A Global Health Alert.

Authors:  Hamid Nasri
Journal:  Iran J Public Health       Date:  2014-01       Impact factor: 1.429

5.  IgM nephropathy: timely response to a call for action.

Authors:  Muhammed Mubarak; Hamid Nasri
Journal:  J Renal Inj Prev       Date:  2013-11-02

6.  Late relapse of IgM nephropathy-associated nephrotic syndrome after repeated administration of immune checkpoint inhibitor against pulmonary adenocarcinoma.

Authors:  Kentaro Odani; Mitsuhiro Tachibana; Fumiaki Nogaki; Yutaka Tsutsumi
Journal:  Clin Case Rep       Date:  2021-03-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.